Windar Photonics guides record 2025 revenue but misses consensus on delayed China order
Windar Photonics has flagged a record year for 2025, but it comes with a sting in the tail. The Company now expects revenue of €6.5m-€6.8m for FY 2025, around 45% up on 2024, with improved gross margins helping EBITDA to move to roughly break-even. However, that top line is well below the Company’s stated consensus for the year – €9.45m of revenue and €2.2m of EBITDA – due to a delayed, large order in China that has slipped into 2026.
At this stage in Windar’s scale-up, single large orders can swing the needle. Management says the products for the China order are ready to ship, which suggests timing rather than technology is the issue, but it still dents the FY 2025 outcome. The wider demand picture looks encouraging, with customers increasingly focused on Windar’s LiDAR-assisted optimisation solution that can lift wind turbine power output by 2-4% and deliver a typical return on investment within two years.
Why the China order delay matters for the investment case
Windar is transitioning from a small to a materially larger business. That means revenue is still concentrated and sensitive to lumpy orders. The delayed China contract is described as having a “significant gross value”, and the slip alone is the key reason guidance falls short of market expectations.
The good news: products are built and ready to ship, and management expects the revenue to land in FY 2026. The bad news: investors have to wait, and any further slippage would undermine confidence. For a company at this stage, execution and timing are just as important as raw demand.
Margins and EBITDA – turning the corner, but not yet through
Gross margins have improved, which is exactly what you want to see as volumes scale. EBITDA – a cash profit proxy before interest, tax, depreciation and amortisation – is expected to be neutral for FY 2025, a marked step up from a loss in 2024 (amount not disclosed). That suggests better unit economics and improved cost discipline.
However, the shortfall to consensus EBITDA (€2.2m expected) is meaningful. The China delay is the explicit driver; without it, 2025 could have looked very different. The focus now shifts to how quickly those higher-margin shipments convert in 2026.
Operational upgrades: five-fold manufacturing capacity and new sales leadership
Windar has clearly been preparing for scale. The Company opened a “future-proof” manufacturing facility during 2025, increasing production capacity five-fold. That is a big investment signal, and it should reduce operational bottlenecks as orders ramp.
On the commercial side, Windar appointed new Vice Presidents of Sales for Europe and North America in August and September respectively, and established an Advisory Board of industry figures. These are the sort of hires and governance enhancements you want ahead of a broader commercial rollout, especially across multiple turbine platforms and geographies.
Platform traction across Vestas, Siemens, GE and Senvion
The RNS points to fresh test orders in North America and Germany across Senvion, Vestas, Siemens and General Electric turbine platforms. That breadth matters: platform compatibility tends to unlock larger addressable fleets once proofs-of-concept convert into standardised deployments.
One datapoint stands out: Windar expects its products to be installed on roughly 25% of all V82 turbines in North America. While not quantified in revenue terms, that gives a flavour of penetration in a defined, recognisable fleet.
What this could mean for 2026
Management’s tone is confident about 2026. With manufacturing capacity now in place, a strengthened sales team, and broadened platform testing, the ingredients for another growth year are present. The CEO also highlights “balance sheet strength”, though no cash or net debt figures are disclosed.
The swing factors are straightforward: closing and shipping the delayed China order, converting 2025 test projects into multi-site or fleet-level rollouts, and sustaining the margin gains seen this year. If those land, 2026 could show operating leverage.
Key numbers from the RNS
| Metric | Guidance/Detail |
|---|---|
| FY 2025 revenue | €6.5m-€6.8m (record; ~45% growth vs 2024) |
| FY 2025 EBITDA | Expected neutral (vs a loss in 2024) |
| Consensus for FY 2025 | Revenue €9.45m; EBITDA €2.2m |
| Gross margin | Improved (no figure disclosed) |
| China order | Delayed; products ready to ship; expected to move to FY 2026 |
| Production capacity | New facility; 5x increase |
| Technology impact | 2-4% turbine power output improvement; typical ROI within two years |
| Platform traction | Tests across Senvion, Vestas, Siemens, GE; ~25% of North American V82 turbines expected to have Windar products |
Risks and things to track from here
- Order concentration: The update shows sensitivity to single, large orders. Diversifying the order book remains a priority.
- Timing risk in China: The delayed order is the difference between meeting and missing guidance. Watch for shipment confirmation and revenue recognition cadence in early 2026.
- Conversion of trials: Tests are great, but investors should look for named rollouts or repeat orders across the major platforms mentioned.
- Margin progression: Gross margin improved in 2025; sustaining that while scaling the new facility will be key to moving EBITDA decisively positive.
- Cash and balance sheet: Management cites “balance sheet strength,” but no figures are disclosed. Any future update with cash runway detail would add confidence.
My take for retail investors
This is a classic scale-up story: operationally more robust, with real customer traction, but still exposed to big-order timing. The headline miss versus consensus will likely disappoint, yet the underlying indicators – five-fold capacity, cross-platform tests, and a tangible installed base on a known turbine class – point in the right direction.
If you believe in the adoption curve for LiDAR optimisation on existing fleets, Windar’s proposition is straightforward: a 2-4% power uplift with a two-year payback is a compelling pitch to wind farm owners. The 2025 miss is about timing rather than demand, according to the Company. The job for 2026 is execution – ship the China order, convert trials, keep margins improving.
Net-net, I see a credible growth setup with operational groundwork laid, balanced by near-term volatility from order timing. Expect share price bumps around contract news. The next major catalyst is evidence that the delayed order really does drop into 2026 and that the test programmes translate into volume deployments.
